Articles On Avita Medical (ASX:AVH)
| Title | Source | Codes | Date |
|---|---|---|---|
|
ASX 200 Performance: MQG, REA, AVH Impact Amid Global Trade Momentum
Highlights: ASX 200 opened slightly higher following overseas market cues driven by diplomatic trade developments Macquarie Group, REA Group, and Avita Medical released sector-aligned performance updates Commodity prices and... |
Kalkine Media | AVH | 6 months ago |
|
ASX Market Open: Aussie market to open slightly up on trade hopes as Wall St surges | May 9, 2025
The ASX200 is set to open slightly higher (up 0.06%) today, following a US rally buoyed by hopes that the trade tensions sparked by Donald Trump’s tariff policy could be resolved. Listen to the HotCopper podcast for in-depth discussions... |
themarketonline.com.au | AVH | 6 months ago |
|
ASX 200 Earnings and Dividend Watch: NAB, ANZ, WBC, REA, RMD and More Release Results
Highlights: Key earnings released this week span banking, mining, real estate, and medical technology ASX 200 members including NAB, ANZ, WBC, and MQG reported results for FY25 or HY25 ResMed Inc declared a dividend with ex-... |
Kalkine Media | AVH | 7 months ago |
|
ASX health April winners and losers: Sector rises 2pc in stronger month for markets
The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR... |
Stockhead | AVH | 7 months ago |
|
Health Check: Yippee! Biotechs join broader rally after Trump tariff turnaround
Nova Eye and Syntara led today’s biotech relief rally, after the sector sunk on Wednesday on the back of a flagged US pharmaceutical tariff Flu vaccines don’t give you autism, but do they work? Recce is raising up to $15.8 million to fund... |
Stockhead | AVH | 7 months ago |
|
ASX ChartWatch Daily Scans: Key Uptrends and Downtrends to Monitor
Highlights: Alkane Resources, Antipa Minerals, and Commonwealth Bank show significant strength. BHP, Fortescue, and Pilbara Minerals indicate troubling downtrends. Various ETFs in precious metals such as gold and silver show... |
Kalkine Media | AVH | 8 months ago |
|
Scott Power: ‘Skip in our step’ as ASX health stocks shrug off losing streak
ASX health stocks break losing streak, up 1.78% over past week, while the broader market rises 2.01% Nanosonics receives US FDA De Novo clearance for its flexible endoscope cleaning system Coris Sigma’s full-year FY25 results as a stand al... |
Stockhead | AVH | 8 months ago |
|
Guess which ASX All Ords stock just leapt 9% on big US news
The All Ordinaries Index (ASX: XAO) is up 0.7% in morning trade with one ASX All Ords stock racing ahead of those gains. The outperforming stock in question is Avita Medical Inc (ASX: AVH). Shares in the regenerative medicine company close... |
Motley Fool | AVH | 8 months ago |
|
Scott Power: ASX health stocks feel force of market volatility
ASX health stocks fall 3.65% over past week, while the broader market is down 2.04% Morgans anlayst Scott Power said there’s a risk-off sentiment among investors with concerns about US tariffs Sigma Healthcare and Pro Medicus elevated to... |
Stockhead | AVH | 8 months ago |
|
Scott Power: Market Volatility Takes a Toll on ASX Health Stocks
Highlights: ASX healthcare sector sees a decline amid global economic uncertainties and market fluctuations. Notable index changes include Sigma Healthcare and Pro Medicus joining the S&P/ASX 50, while Ramsay Health Care exit... |
Kalkine Media | AVH | 8 months ago |
|
FNArena Corporate Results Monitor – 07-03-2025
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today’s Reports: ((AHL)) – Adrad... |
FNArena | AVH | 9 months ago |
|
ASX February health winners: Sector falls almost 8pc in weaker month for markets
The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA Pacific Edge was... |
Stockhead | AVH | 9 months ago |
|
The Overnight Report: Season Ends On Sour Note
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US equities yet again tried to rally overnight but it wasn’t to be. As President Tru... |
FNArena | AVH | 9 months ago |
|
Health Check: More, please! When record results are not good enough for expectant investors
Polynovo and Avita Medical are victims of skittish market behaviour Cyclopharm breathes easier after a good start with US sales Control Bionics raises $2 million to rev up commercialisation Investor reaction to PolyNovo’s (ASX:PNV) half... |
Stockhead | AVH | 9 months ago |
|
ASX Sets New High as Avita Medical Surges 11% Amid Broad Market Gains
Highlights ASX 200 inches toward record close despite global trade concerns. Avita Medical (ASX:AVH) jumps 11.6% on strong revenue growth and 2025 outlook. Technology and gold sectors lead gains, while Cochlear (ASX:COH) and AMP (ASX:... |
Kalkine Media | AVH | 9 months ago |
|
ASX Market Update: IT stocks lead Aussie bourse higher | February 14, 2025
The ASX200 has been up 0.5% at 8,582 points. The Aussie index pared early gains as speculation continues to swirl around the RBA’s rate decision due next week. IT and Staples have been the best performing sectors, up 1.5%, followed by... |
themarketonline.com.au | AVH | 9 months ago |
|
Avita Medical Surges on Strong Revenue Growth Forecast
Highlights Avita Medical (NASDAQ:RCEL) projects a 55%-65% revenue increase in 2025. Company anticipates GAAP profitability by Q4 2025. Shares rise nearly 11% after the announcement. Avita Medical (NASDAQ:RCEL) saw a strong boo... |
Kalkine Media | AVH | 9 months ago |
|
2 ASX All Ords shares soaring on strong full year results
Earnings season has continued to heat up on Friday with another set of result releases. Two ASX All Ords shares that have released strong full year results today are listed below. Let's see what they reported: AVITA Medical Inc (ASX: AVH)... |
Motley Fool | AVH | 9 months ago |
|
Health Check: Good golly Miss Molly! Emyria says Ecstasy works for PTSD, months after treatment
Emyria says its ‘real world’ MDMA trial shows a “sustained improvement” in post-traumatic stress disorder (PTSD) symptoms Argenica says its traumatic brain injury candidate works in rats – and ferrets The biotech sector advanced to recor... |
Stockhead | AVH | 10 months ago |
|
ASX January winners: ASX reaches record high but February off to a rocky start
The S&P/ASX 200 rose 5% in January to reach a new record high Utilities was the only sector to fall in January with financials the top performer AusQuest tops January winners up 388% with discovery of a large-scale Peruvian copper pros... |
Stockhead | AVH | 10 months ago |
|
Bell Potter says this ASX share is a 'small-cap investment opportunity'
If you are looking for exposure to the small side of town, then it could be worth checking out the small cap ASX share in this article. That's because analysts at Bell Potter are tipping it as a top buy in 2025. Let's see what the broker is... |
Motley Fool | AVH | 10 months ago |
|
The Overnight Report: Bond Yields In Focus
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8211.00 + 40.00 0.49% S&P ASX 200 8191.90 –... |
FNArena | AVH | 10 months ago |
|
ASX Retreats Amid Profit-Taking and Mixed Economic Data
Highlights ASX ends a five-day rally, led by losses across industrial stocks. Retail sales growth underwhelms expectations, adding to cautious sentiment. Star Entertainment (SGR) suffers a dramatic plunge, losing a third of its value.... |
Kalkine Media | AVH | 10 months ago |
|
ASX Market Close: Retail sales slower than expected as bourse pulls back | January 9, 2025
The ASX200 closed down 0.24% at 8,329 points, breaking a five-day rally. Australian retail sales rose slower than expected in November, growing 0.8% month over month in November, up from 0.5% growth in the prior quarter. To the boards... |
themarketonline.com.au | AVH | 10 months ago |
|
Closing Bell: ASX slips, Star crashes 27pc and China faces fresh deflation woes
ASX slips as retail data dampens rate cut hopes Star Entertainment crashes 27% on cash burn warning Bitcoin dips, China faces fresh deflation fears After five days of gains, the ASX took a breather on Thursday, dipping 0.24% as retail s... |
Stockhead | AVH | 10 months ago |
|
ASX Faces Challenges as Consumer Spending Concerns and Corporate Warnings Impact the Market
Highlights ASX experiences a 0.4% drop, led by significant sell-offs in energy and industrial sectors. Consumer spending data raises doubts about immediate interest rate cuts. Star Entertainment (SGR) experiences a dramatic 25.6% plun... |
Kalkine Media | AVH | 10 months ago |
|
ASX Struggles Amid Economic Concerns as Key Stocks Drop
Highlights ASX 200 index suffers a 0.4% decline with broad-based sector losses. Retail sales data raises concerns about interest rate cuts. Star Entertainment (SGR) and Lovisa (LOV) face heavy losses. The Australian stock mark... |
Kalkine Media | AVH | 10 months ago |
|
Why AVITA Medical, Lovisa, Star, and Westgold shares are sinking today
The S&P/ASX 200 Index (ASX: XJO) is out of form and dropping into the red on Thursday. In afternoon trade, the benchmark index is down 0.4% to 8,314.6 points. Four ASX shares that are falling more than most today are listed below. Her... |
Motley Fool | AVH | 10 months ago |
|
ASX Retreats After Five-Day Rally Amid Retail Sales Concerns
Highlights Australian markets ended a five-day rally as retail sales data raises rate concerns. Energy, mining, and banking sectors led the decline amid falling oil prices. Star Entertainment (SGR) saw a steep decline due to cash f... |
Kalkine Media | AVH | 10 months ago |
|
Investors wipe $110m off AVITA Medical shares as full-year revenue target downgraded
Shares in regenerative medicine company AVITA Medical Inc (ASX: AVH) closed 19 per cent lower today after the company revised down its full-year revenue guidance due to a slowdown in sales during December. The Perth-founded AVITA, which pr... |
businessnewsaustralia.com | AVH | 10 months ago |
|
Closing Bell: ASX surges after inflation shock; banks and goldies lead the charge
ASX up again after surprise inflation spike Miners led gains as financials rode rate bet Energy Transition Minerals soared on Trump talk The ASX kept its momentum rolling, up 0.77% on Wednesday as an inflation report surprise gave the R... |
Stockhead | AVH | 10 months ago |
|
ASX Gains Nearly 1% as Financials and Miners Lead Rally
Highlights Cooling inflation boosts market confidence amid potential rate cuts. Financial heavyweights CBA and NAB rise over 2%, driving the ASX upward. Miners recover as key stocks like BHP and RIO rebound from recent losses. The... |
Kalkine Media | AVH | 10 months ago |
|
Health Check: Which stock just dumped 19% on earnings downgrade?
Wound care company Avita Medical slumps ~19% on downgrade of its earnings guidance Infection-control medtech Next Science hit with legal action by a former employee Biotech Orthocell achieves third consecutive quarter of record revenue ... |
Stockhead | AVH | 11 months ago |
|
ASX Gains Ground as Inflation Cools, Avita Medical Faces Setback
Highlights Core inflation drops, leading to a recovery in the ASX. Miners show strong performance, while uranium stocks take a hit. Avita Medical (AVH) downgraded revenue outlook, causing a sharp dip. The Australian sharemarke... |
Kalkine Media | AVH | 11 months ago |
|
Why AVITA Medical, Block, Computershare, and GQG Partners shares are falling today
The S&P/ASX 200 Index (ASX: XJO) has rebounded from a poor start and pushing higher on Wednesday. In afternoon trade, the benchmark index is up 0.4% to 8,317.1 points. Four ASX shares that have failed to rise with the market today are... |
Motley Fool | AVH | 11 months ago |
|
Inflation Concerns and Wall Street Weakness Weigh on ASX: Avita Medical (ASX:AVH) Leads Losses
Highlights Australian share market opens lower amid inflation concerns. Avita Medical's guidance downgrade drives a sharp decline. Mixed performance seen across key sectors and major companies. The Australian share market expe... |
Kalkine Media | AVH | 11 months ago |
|
Why did this ASX All Ords stock just crash 17%?
AVITA Medical Inc (ASX: AVH) shares are having a tough time on Wednesday. In morning trade, the ASX All Ords stock is down 17% to $3.62. Why is this ASX All Ords stock down 17%? This commercial-stage regenerative medicine company's shares a... |
Motley Fool | AVH | 11 months ago |
|
ASX December health sector winners… and a 91pc drop for a trial-flopped stock
The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024 Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece... |
Stockhead | AVH | 11 months ago |
|
Why DroneShield, Invictus Energy, Mesoblast, Weebit Nano shares are rising today
In early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to finish the year with another decline. At the time of writing, the benchmark index is down 0.7% to 8,174.7 points. Four ASX shares that are not letting that hol... |
Motley Fool | AVH | 11 months ago |
|
Why AVITA Medical, Life360, Newmont, and St Barbara shares are falling today
The S&P/ASX 200 Index (ASX: XJO) is having a disappointing finish to the year. At the time of writing, the benchmark index is down 0.7% to 8,174.7 points. Four ASX shares that are falling more than most today are listed below. Here's... |
Motley Fool | AVH | 11 months ago |
|
Why Bowen Coal, Droneshield, Mesoblast, and St Barbara shares are racing higher today
The S&P/ASX 200 Index (ASX: XJO) is on form again after returning from the Christmas break. At the time of writing, the benchmark index is up 0.4% to 8,255.7 points. Four ASX shares that are rising more than most today are listed below... |
Motley Fool | AVH | 11 months ago |
|
ASX Market Close: Local bourse manages last gasp of green cheer heading into Chrissy shutdown | Dec 24, 2024
The ASX 200 ended on a positive closing note before Santa’s arrival (a fair bit) later this evening with a 0.29% gain, adding a short 24 points to 8,217. Real Estate was today’s top sector leader, ending the day up 0.82%, followed by Hea... |
themarketonline.com.au | AVH | 11 months ago |
|
Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher
The S&P/ASX 200 Index (ASX: XJO) is having a volatile session but is currently on course to record a small gain. In early afternoon trade, the benchmark index is up slightly to 8,208.5 points. Four ASX shares that are rising more than m... |
Motley Fool | AVH | 11 months ago |
|
Leading brokers name 3 ASX shares to buy today
With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading... |
Motley Fool | AVH | 11 months ago |
|
Guess which ASX healthcare stock is jumping 7% on US FDA approval news
AVITA Medical Inc (ASX: AVH) shares are having a strong start to the day. In morning trade, the ASX healthcare stock is up over 7% to $4.10. Why is this ASX healthcare stock jumping? Investors have been buying the regenerative medicine comp... |
Motley Fool | AVH | 11 months ago |
|
ASX Market Open: Short trade day for Chrissy Eve to barely stay green after yesterday’s rocket run | Dec 24, 2024
The ASX 200 is expected to stay ever so slightly in the green at open on Christmas Eve after the Wall Street Santa rush (mostly) ploughed on through weaker-than-expected U.S. consumer confidence reported on Monday. The Magnificent Seven... |
themarketonline.com.au | AVH | 11 months ago |
|
Stocking stuffers: Morgans’ top ASX health picks for 2025
Morgans sees opportunities among several ASX healthcare stocks in 2025 Broker looking at stocks with near-term catalysts or sold down with good entry opportunities Morgans’ Christmas stocking has mix of up-and-comers alongside mature names... |
Stockhead | AVH | 11 months ago |
|
Health Check: Can Syntara produce the next multibillion-dollar Aussie blood cancer drug?
Syntara aims for FDA ‘breakthrough’ therapy status for its myelofibrosis drug candidate FAK! More promising results from Amplia’s pancreatic cancer trial Oh, you shouldn’t have! Broker Morgans’ Christmas biotech hamper Armed with encour... |
Stockhead | AVH | 11 months ago |
|
Dr Boreham’s Crucible: ‘The sun is coming up’ for this skin-regeneration specialist
When it comes to medical devices, improving the lives of clinicians is just as important as improving the lives of patients. If both these aims can be achieved, that’s the sweet spot. In the case of Avita Medical (ASX:AVH), the company’s ap... |
Stockhead | AVH | 11 months ago |
|
ASX November Health Winners: Paradigm, Imricor lead sector as momentum returns
The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX Paradigm Biopharmaceuticals rose 151% in Novembe... |
Stockhead | AVH | 1 year ago |